Clin2
NCT07306988Possibly a fitRecruiting

Treating H. pylori to improve metabolic syndrome

HELICOBACTER PYLORI INFECTIONSMetabolic Syndrome

Part of Hormones & metabolism clinical trials.

This trial tests whether treating H. pylori infection can help improve metabolic syndrome (a group of conditions like high blood sugar, abnormal cholesterol, and high blood pressure). It aims to understand how treatment changes your gut bacteria and overall health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
120 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been newly diagnosed with metabolic syndrome by your doctor.
  • You have an active H. pylori infection confirmed by a breath test and have never been treated for it.
  • You are not taking any medicines for blood sugar, cholesterol, or weight loss.
  • You have not taken antibiotics or stomach-acid-reducing drugs recently.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07757919Not yet recruiting· Phase 4
14-day treatment for H. pylori infection

This trial tests a 14-day course of two medicines, vonoprazan and minocycline, to see how well they clear an H. pylori stomach infection. If you have H. pylori and haven't been treated for it before, this study may help you get rid of the infection.

NCT07130253Not yet recruiting
New treatment for stubborn H. pylori infection

This trial tests a new combination of medicines to get rid of H. pylori bacteria in people whose previous treatments have not worked. It aims to find a more effective way to clear the infection.

Taipei
NCT07576959Recruiting· Phase 3
Bismuth with dual therapy for H. pylori infection treatment

This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.

Taipei
NCT07501858Recruiting
H. pylori and insulin resistance in metabolic syndrome

This study looks at whether a common stomach infection (H. pylori) affects insulin resistance in people with metabolic syndrome. It uses simple tests like a breath test, stool sample, and blood draw to check if treating the infection could help improve metabolic health.

Novosibirsk, Novosibirsk Oblast
NCT07179159Recruiting
14-day stomach infection treatment study

This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.

Jinan, Shandong
NCT07293910Recruiting· Phase 2
Comparing stomach acid drugs for clearing H. pylori infection

This trial tests different combinations of stomach acid-reducing drugs, vitamin D or probiotics, to see which works best for clearing an H. pylori infection. H. pylori is a common stomach bacteria that can cause ulcers or stomach discomfort.

Shibīn al Kawm

Hear when a new Metabolic Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.